Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption
Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing
Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer
Apollo Silver Closes First Tranche of $27.5 Million Private Placement Offering Including $2.355 Million Investment from Insiders